CFTR and cystic fibrosis: Although these studies are promising given the potential of these various gene repair systems to restore native CFTR function in human models of CF, this therapy is based on introducing DNA strand breaks into native host DNA—an event that is, under normal circumstances, considered unwelcome and capable of significant collateral genetic damage.